Literature DB >> 15772787

Acute mesenteric ischemia: the challenge of gastroenterology.

Hiroshi Yasuhara1.   

Abstract

Intestinal ischemia has been classified into three major categories based on its clinical features, namely, acute mesenteric ischemia (AMI), chronic mesenteric ischemia (intestinal angina), and colonic ischemia (ischemic colitis). Acute mesenteric ischemia is not an isolated clinical entity, but a complex of diseases, including acute mesenteric arterial embolus and thrombus, mesenteric venous thrombus, and nonocclusive mesenteric ischemia (NOMI). These diseases have common clinical features caused by impaired blood perfusion to the intestine, bacterial translocation, and systemic inflammatory response syndrome. Reperfusion injury, which exacerbates the ischemic damage of the intestinal microcirculation, is another important feature of AMI. There is substantial evidence that the mortality associated with AMI varies according to its cause. Nonocclusive mesenteric ischemia is the most lethal form of AMI because of the poor understanding of its pathophysiology and its mild and nonspecific symptoms, which often delay its diagnosis. Mesenteric venous thrombosis is much less lethal than acute thromboembolism of the superior mesenteric artery and NOMI. We present an overview of the current understanding of AMI based on reported evidence. Although AMI is still lethal and in-hospital mortality rates have remained high over the last few decades, accumulated knowledge on this condition is expected to improve its prognosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772787     DOI: 10.1007/s00595-004-2924-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  68 in total

1.  Mesenteric venous thrombosis.

Authors:  Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2011-12-08       Impact factor: 2.007

Review 2.  Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-11-19       Impact factor: 3.445

Review 3.  Intestinal ischemia: current treatment concepts.

Authors:  Philipp Renner; Klaus Kienle; Marc H Dahlke; Peter Heiss; Karin Pfister; Christian Stroszczynski; Pompiliu Piso; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2010-11-12       Impact factor: 3.445

4.  The diagnostic labyrinth.

Authors:  Pietro Amedeo Modesti
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

5.  Non-invasive diagnosis of acute mesenteric ischaemia using PET.

Authors:  Jan Kiss; Alexandru Naum; Nobuyuki Kudomi; Juhani Knuuti; Patricia Iozzo; Timo Savunen; Pirjo Nuutila
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-11       Impact factor: 9.236

6.  The effectiveness of gastric tonometry in the diagnosis of acute mesenteric ischemia in cases where a contrast-enhanced computed tomography cannot be obtained.

Authors:  Bahadır Öz; Muhammet Akyüz; Ertan Emek; Erdoğan Sözüer; Hızır Akyıldız; Alper Akcan; Engin Ok
Journal:  Ulus Cerrahi Derg       Date:  2014-10-20

7.  A rare cause of acute mesenteric ischemia: JAK2 positivity and chronic active hepatitis B.

Authors:  Mehmet Baykan; Kürşat Gündoğan; Hızır Yakup Akyıldız; Mustafa Alper Yurci
Journal:  Ulus Cerrahi Derg       Date:  2013-11-14

8.  Protective effect of the traditional Chinese medicine xuesaitong on intestinal ischemia-reperfusion injury in rats.

Authors:  Xuan Xu; Dengxiao Li; Hong Gao; Yuejin Gao; Long Zhang; Yuling Du; Jian Wu; Pengfei Gao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 9.  [Multidetector computed tomography in abdominal emergencies].

Authors:  N Zorger; A G Schreyer
Journal:  Radiologe       Date:  2009-06       Impact factor: 0.635

10.  Alpha-lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine.

Authors:  Ahmet Guven; Turan Tunc; Turgut Topal; Mustafa Kul; Ahmet Korkmaz; Gokhan Gundogdu; Onder Onguru; Haluk Ozturk
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.